Everest Organics Limited (524790) Fair Value & Analysis
Other · IN · Market cap ₹2.0B
Fair value as of: Jul 4, 2026
From 23 valuation models · updated today
Share price +15.6% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹203.45 – ₹522.50 · fair‑value band ₹73.84 – ₹147.33 · the ₹270.45 price screens above the ₹99.06 fair value. As of Jul 4, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Everest Organics Limited (524790) currently trades at ₹270.45, while our model-based Fair Value estimate is ₹99.06 — implying the stock looks roughly 63.4% overvalued today. We read business quality at 36/100 (below-average quality), in the Other sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Everest Organics Limited generated revenue of ₹1.7B at a net margin of 7.6%. Revenue grew 12.2% year over year. It earns a return on equity of 37.3%. Net debt stands at ₹498M. Fundamentals as of Jul 4, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 4, 2026. TTM = trailing twelve months.
About the company
Everest Organics Limited manufactures and sells active pharmaceutical ingredients and intermediaries. The company also manufactures bulk drugs. It exports bulk drugs, intermediates, drug formulations, biologicals, Ayush and herbal, and surgical products to the United States, Western Europe, Eastern Europe, South America, Egypt, Australia, Germany, Saudi Arabia, Dubai, China, Vietnam, Iran, Singapore, Indonesia, Bangladesh, Pakistan, Sri Lanka, and other Middle East countries. Everest Organics Limited was incorporated in 1993 and is based in Hyderabad, India.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Everest Organics Limited reported revenue of ₹2.0B in FY2025 versus ₹2.0B in FY2021, a compound −0.5%/yr. Reported net income was ₹55.5M in FY2025, compounding +48.4%/yr from FY2021.
Is 524790 fairly valued? → Check now
Similar stocks
6 more Other stocks, each showing price versus our Fair Value estimate (as of Jul 4, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| There MOH | €521.90 | €269.92 | -48% |
| Sony Corporation SON1 | €17.58 | €37.56 | +114% |
| Federal Home Loan Mortgage Corporation FREJO | $16.84 | $64.93 | +286% |
| 533278 533278 | ₹438.60 | ₹720.31 | +64% |
| Nestl?? India Limited 500790 | ₹1,459 | ₹279.60 | -81% |
| 540376 540376 | ₹3,993 | ₹1,806 | -55% |
Explore undervalued stocks
Frequently asked questions
Is Everest Organics Limited (524790) undervalued?
What is the fair value of 524790?
What is the quality score of 524790?
What is the revenue of Everest Organics Limited (524790)?
What is the net profit margin of 524790?
Does Everest Organics Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.